Publications and Whitepapers

Synthetic Biology for Chemical Production

Alexandre Zanghellini, Arzeda’s CEO, penned an overview of both the current and the future impact of synthetic biology upon the chemicals industry. It highlights the opportunities that can be opened through the simultaneous advance of several technologies- improved fermentation strategies, development of biological FABs, designer biocatalysts, and improved synthetic DNA. Arzeda is at the forefront


INVISTA receives patent for bio-derived raw materials technology developed through collaboration with Arzeda

…Alexandre Zanghellini, co-founder and chief executive officer at Arzeda, said, “The issuance of this patent is yet another example of the power of combining Arzeda’s computational protein design technology Archytas™ with experimental screening to rapidly design synthetic enzymes. With INVISTA’s expertise in biotechnology and industrial scale-up, we are confident this collaboration will lead to advanced

Download PDF

SBOL Visual: A Graphical Language for Genetic Designs

One of the team members at Arzeda recently published a paper advancing a standard for a common language for use across synthetic biology. Well done, Michal!